306 related articles for article (PubMed ID: 35796138)
21. Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Yip SM; Wells C; Moreira R; Wong A; Srinivas S; Beuselinck B; Porta C; Sim HW; Ernst DS; Rini BI; Yuasa T; Basappa NS; Kanesvaran R; Wood LA; Canil C; Kapoor A; Fu SYF; Choueiri TK; Heng DYC
Cancer; 2018 Sep; 124(18):3677-3683. PubMed ID: 30307610
[TBL] [Abstract][Full Text] [Related]
22. Impact of skeletal muscle mass on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Uchida Y; Ishii H; Tanaka A; Yonekawa J; Satake A; Makino Y; Suzuki W; Kurobe M; Mizutani K; Mizutani Y; Fujimoto M; Ichimiya H; Teramoto C; Tamenishi A; Okamoto H; Watanabe J; Kanashiro M; Amano T; Matsubara T; Ichimiya S; Murohara T
Cardiovasc Interv Ther; 2021 Oct; 36(4):514-522. PubMed ID: 33128695
[TBL] [Abstract][Full Text] [Related]
23. Sarcopenia Defined by Psoas Muscle Thickness Predicts Mortality After Transjugular Intrahepatic Portosystemic Shunt.
Li T; Liu J; Zhao J; Bai Y; Huang S; Yang C; Wang Y; Zhou C; Wang C; Ju S; Chen Y; Yao W; Xiong B
Dig Dis Sci; 2023 Apr; 68(4):1641-1652. PubMed ID: 36583804
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of sarcopenia in microsatellite-stable gastric cancer patients treated with programmed death-1 inhibitors.
Kim YY; Lee J; Jeong WK; Kim ST; Kim JH; Hong JY; Kang WK; Kim KM; Sohn I; Choi D
Gastric Cancer; 2021 Mar; 24(2):457-466. PubMed ID: 32970267
[TBL] [Abstract][Full Text] [Related]
25. The psoas muscle index as a predictor of long-term survival after cardiac surgery for hemodialysis-dependent patients.
Kurumisawa S; Kawahito K
J Artif Organs; 2019 Sep; 22(3):214-221. PubMed ID: 31134455
[TBL] [Abstract][Full Text] [Related]
26. Sarcopenia does not limit overall survival in patients with colorectal liver metastases undergoing interstitial brachytherapy.
Thormann M; Heitmann F; Wrobel V; Barajas Ordonez F; Pech M; Surov A; Damm R; Omari J
Rofo; 2023 Mar; 195(3):217-223. PubMed ID: 36283404
[TBL] [Abstract][Full Text] [Related]
27. Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Khan AI; Psutka SP; Patil DH; Hong G; Williams MA; Bilen MA; Sekhar A; Kissick HT; Narayan VM; Joshi SS; Ogan K; Master VA
Cancer; 2022 Jun; 128(11):2073-2084. PubMed ID: 35285950
[TBL] [Abstract][Full Text] [Related]
28. Prognostic and predictive factors to nivolumab in patients with metastatic renal cell carcinoma: a single center study.
Mollica V; Rizzo A; Tassinari E; Giunchi F; Schiavina R; Fiorentino M; Brunocilla E; Ardizzoni A; Massari F
Anticancer Drugs; 2021 Jan; 32(1):74-81. PubMed ID: 33290315
[TBL] [Abstract][Full Text] [Related]
29. C-reactive protein and the neutrophil-to-lymphocyte ratio are prognostic biomarkers in metastatic renal cell carcinoma patients treated with nivolumab.
Suzuki K; Terakawa T; Furukawa J; Harada K; Hinata N; Nakano Y; Fujisawa M
Int J Clin Oncol; 2020 Jan; 25(1):135-144. PubMed ID: 31512006
[TBL] [Abstract][Full Text] [Related]
30. Progressive Sarcopenia in Patients With Colorectal Cancer Predicts Survival.
Deng CY; Lin YC; Wu JS; Cheung YC; Fan CW; Yeh KY; McMahon CJ
AJR Am J Roentgenol; 2018 Mar; 210(3):526-532. PubMed ID: 29364725
[TBL] [Abstract][Full Text] [Related]
31. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
32. Sarcopenia and anthracycline cardiotoxicity in patients with cancer.
Bas O; Erdemir AG; Onur MR; Ozer N; Sener YZ; Aksu S; Barista I; Guner G; Guven DC; Kertmen N; Aksoy S; Turker A; Dizdar O
BMJ Support Palliat Care; 2023 Dec; 13(4):453-461. PubMed ID: 34479960
[TBL] [Abstract][Full Text] [Related]
33. Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell Carcinoma.
Auclin E; Bourillon C; De Maio E; By MA; Seddik S; Fournier L; Auvray M; Dautruche A; Vano YA; Thibault C; Joly F; Brunereau L; Gomez-Roca C; Chevreau C; Elaidi R; Oudard S
Clin Genitourin Cancer; 2017 Jun; 15(3):350-355. PubMed ID: 28216276
[TBL] [Abstract][Full Text] [Related]
34. Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients.
Kano M; Hihara J; Tokumoto N; Kohashi T; Hara T; Shimbara K; Takahashi S
Int J Clin Oncol; 2021 Mar; 26(3):523-531. PubMed ID: 33226523
[TBL] [Abstract][Full Text] [Related]
35. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
[TBL] [Abstract][Full Text] [Related]
36. Cut-off values of skeletal muscle index and psoas muscle index at L3 vertebra level by computerized tomography to assess low muscle mass.
Bahat G; Turkmen BO; Aliyev S; Catikkas NM; Bakir B; Karan MA
Clin Nutr; 2021 Jun; 40(6):4360-4365. PubMed ID: 33516603
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma.
Yamamoto Y; Matsuyama H; Matsumoto H; Sakano S; Fuji N; Oba K; Yamamoto M; Kamiryo Y; Hiragino T; Nagao K; Takai K; Aoki A
Jpn J Clin Oncol; 2020 Feb; 50(2):214-220. PubMed ID: 31755525
[TBL] [Abstract][Full Text] [Related]
38. Correlation between the magnitude of best tumor response and patient survival in nivolumab therapy for metastatic renal cell carcinoma.
Ishihara H; Takagi T; Kondo T; Tachibana H; Fukuda H; Yoshida K; Iizuka J; Kobayashi H; Okumi M; Ishida H; Tanabe K
Med Oncol; 2019 Mar; 36(4):35. PubMed ID: 30879157
[TBL] [Abstract][Full Text] [Related]
39. Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies.
Okumura S; Kaido T; Hamaguchi Y; Fujimoto Y; Kobayashi A; Iida T; Yagi S; Taura K; Hatano E; Uemoto S
Surgery; 2016 Mar; 159(3):821-33. PubMed ID: 26603849
[TBL] [Abstract][Full Text] [Related]
40. Low muscle mass determined by psoas muscle area does not correlate with dual-energy x-ray absorptiometry or total lumbar muscle mass scores: A prospective cohort study of patients undergoing vascular surgery.
Thurston BE; Thomas JM; Miller M; Delaney CL
Vascular; 2023 Feb; 31(1):107-114. PubMed ID: 35104187
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
